Jun 15, 2006

A peak you reach

Posted in Cancer, spectroscopy at 3:39 pm by David Bradley -- Click to comment

 

Rather than relying on MRI and follow-up biopsy to provide information about a suspect abnormality in the breast, researchers at the Memorial Sloan-Kettering Cancer Center in New York have demonstrated in preliminary trials that NMR spectroscopy could be used to significantly reduce the number of biopsies required to detect the early stages of breast cancer. NMR can lock on to the choline peak associated with malignancy during the MRI scan….

Click to read the full article…

Have your say

May 28, 2006

Cesamet, THC and chemotherapy

Posted in Cancer at 3:03 pm by David Bradley -- Click to comment

 

The drug Cesamet (nabilone), a derivative of tetrahydrocannabinol, was “re-approved” for the clinical market this week for use in treating the side-effects of cancer chemotherapy, including nausea and vomiting. Genetic Engineering News reports that Valeant Pharmaceuticals International (NYSE:VRX) announced that the US Food and Drug Administration (FDA) has given marketing approval for Cesamet (CII) (nabilone) oral capsules. The drug interacts with the CB1 cannabinoid receptor found throughout the nervous system, its interaction with …

Click to read the full article…

Have your say

Mar 20, 2006

Antiperspirants Cause a Stink

Posted in Cancer at 3:00 pm by David Bradley -- Click to comment

 

Philippa Darbre of the University of Reading, England, has published a review of the putative health effects of organometallic compounds that mimic estrogen and could increase the burden of “aberrant oestrogen signalling within the human breast”. Of particular relevance to public health is her suggestion that the aluminum compounds used in the manufacture of underarm antiperspirants may somehow be involved in an increased risk of breast cancer. The paper is already causing a stir in …

Click to read the full article…

Have your say

« Previous entries · Next entries » Blog Archives »